Home / ATXI : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ATXI make money? Does ATXI have pricing power? What's the Earnings Whisper? Will ATXI profit more as the business scales? What is ATXI's management track record? Is ATXI's current price justified?

Avenue Therapeutics, Inc.

$0.6 -$0.09 (-12.52%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$0.82

Day Range

$0.6$0.9

Year Range

$0.15$0.97

Market Cap

1.98M

AVG Volume

4.24K

Trailing/Forward PE

-0.71/-

PEG ratio

-0.03

Dividend Yield

Next Earnings Date

2026-11-13

Primary Exchange

Other OTC

Revenue (USD)

ATXI Revenue (USD) by year
Period	Revenue (USD)
2025	1.4M
2024	0
2023	0
2022	0
2021	0
2020	0
2019	0
2018	0
2017	0
2016	0

Net Income (USD)

ATXI Net Income (USD) by year
Period	Net Income (USD)
2025	-2.91M
2024	-16.15M
2023	-10.38M
2022	-3.55M
2021	-3.73M
2020	-5.15M
2019	-25.91M
2018	-21.55M
2017	-12.26M
2016	-3.18M

Operating Income (USD)

ATXI Operating Income (USD) by year
Period	Operating Income (USD)
2025	-3.29M
2024	-11.28M
2023	-14.54M
2022	-8.04M
2021	-3.74M
2020	-5.21M
2019	-26.27M
2018	-21.82M
2017	-11.42M
2016	-2.38M

EBITDA (USD)

ATXI EBITDA (USD) by year
Period	EBITDA (USD)
2025	-3.25M
2024	-10.86M
2023	-8.04M
2022	5.6M
2021	-3.74M
2020	-4.18M
2019	-26.21M
2018	-21.55M
2017	-11.85M
2016	-2.48M

Cash Flows (USD)

ATXI Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-1.83M
2024	-9.03M
2023	-10.45M
2022	-7.6M
2021	-3.75M
2020	-5.61M
2019	-26.26M
2018	-18.22M
2017	-6.8M
2016	-1.63M

EPS (USD)

ATXI EPS (USD) by year
Period	EPS (USD)
2025	-0.94
2024	-11.53
2023	-135.42
2022	-151.04
2021	-3.3
2020	-4.68
2019	-935.92
2018	-1674.29
2017	-1057.67
2016	-5.39

Expenses (USD)

ATXI Expenses (USD) by year
Period	Expenses (USD)
2025	4.69M
2024	11.28M
2023	15.54M
2022	8.04M
2021	3.74M
2020	6.21M
2019	26.27M
2018	21.82M
2017	11.42M
2016	2.38M

Cash & Debt (USD)

ATXI Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	2.85M
2024	2.59M
2023	1.78M
2022	6.71M
2021	3.76M
2020	3.13M
2019	8.74M
2018	2.67M
2017	21.78M
2016	197K

Debt ratios

ATXI Debt ratios by year
Period	Debt ratios
2025	0.17
2024	0.15
2023	0.17
2022	0.24
2021	0.07
2020	0.05
2019	0.14

Margins

ATXI Margins by year
Period	Margins
2025	-207.19%

Return on Capital

ATXI Return on Capital by year
Period	Return on Capital
2025	-158.79%
2024	-869.94%
2023	-1586.7%
2022	-108.76%
2021	-108.11%
2020	-218.36%
2019	-381%
2018	3414.9%
2017	-63.25%
2016	38.52%

Shares Outstanding

ATXI Shares Outstanding by year
Period	Shares Outstanding
2025	3.13M
2024	1.6M
2023	25.6M
2022	1.41M
2021	1.22M
2020	1.1M
2019	1.09M
2018	687.15K
2017	664.57K
2016	589.43K

Book Value Per Share (USD)

ATXI Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	0.59
2024	1.16
2023	0.03
2022	2.32
2021	2.84
2020	2.14
2019	6.21
2018	-0.92
2017	29.16
2016	-13.99

Total Assets (USD)

ATXI Total Assets (USD) by year
Period	Total Assets (USD)
2025	2.93M
2024	2.67M
2023	1.85M
2022	6.84M
2021	3.96M
2020	3.25M
2019	8.91M
2018	4.53M
2017	22.17M
2016	197K

Employee Count

ATXI Employee Count by year
Period	Employee Count
2025	1
2024	2
2023	3
2022	2
2021	4
2020	4
2019	4
2018	6
2017	2

Free Cash Flow Yield

ATXI Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-70%
Sep 26	-77.14%
Aug 26	-92.93%
Aug 26	-163.06%
Aug 26	-163.06%
Aug 26	-164.65%
Jul 26	-84.97%
Jul 26	-119.51%
Jul 26	-131.77%
Jul 26	-103.33%
Jul 26	-108%
Jun 26	-117.65%
Jun 26	-101.19%
Jun 26	-102.94%
Jun 26	-93.45%
May 26	-109.8%
May 26	-136.75%
May 26	-109.8%
May 26	-62.15%
May 26	-96.28%
Apr 26	-88.7%
Apr 26	-106.44%
Apr 26	-130.09%
Apr 26	-167.26%
Mar 26	-188.79%
Mar 26	-188.79%
Mar 26	-228.13%
Mar 26	-248.86%
Feb 26	-288.16%
Feb 26	-365%
Feb 26	-365%
Feb 26	-285.77%
Jan 26	-271.04%
Jan 26	-135.32%
Jan 26	-78.21%
Jan 26	-73.2%
Jan 26	-79.82%
Dec 25	-85.31%
Dec 25	-83.99%
Dec 25	-84.19%
Dec 25	-71.2%
Nov 25	-71.61%
Nov 25	-70.27%
Nov 25	-72.03%
Nov 25	-210.01%
Oct 25	-218.79%
Oct 25	-221.78%
Oct 25	-215.76%
Oct 25	-221.84%
Oct 25	-225.04%
Sep 25	-196.91%
Sep 25	-207.25%
Sep 25	-192.11%
Sep 25	-214.32%
Aug 25	-276.37%
Aug 25	-271.6%
Aug 25	-276.37%
Aug 25	-478.99%
Aug 25	-518.93%
Jul 25	-600.98%
Jul 25	-568.35%
Jul 25	-653.99%
Jul 25	-702.29%
Jun 25	-992.96%
Jun 25	-799.02%
Jun 25	-1146.81%
Jun 25	-918.11%
May 25	-1095.74%
May 25	-1143.34%
May 25	-1084.54%
May 25	-2350.52%
May 25	-2238.59%
Apr 25	-2238.59%
Apr 25	-2128.37%
Apr 25	-2168.96%
Apr 25	-2168.04%
Mar 25	-2127.48%
Mar 25	-1827.69%
Mar 25	-837.5%
Mar 25	-675.13%
Feb 25	-601.48%
Feb 25	-486.49%
Feb 25	-486.49%
Feb 25	-542.32%
Jan 25	-486.49%
Jan 25	-350.07%
Jan 25	-357.64%
Jan 25	-365.54%
Jan 25	-321.18%
Dec 24	-341.04%
Dec 24	-373.8%
Dec 24	-367.57%
Dec 24	-359.58%
Nov 24	-307.73%
Nov 24	-329.17%
Nov 24	-342.81%
Nov 24	-391.52%
Nov 24	-382.78%
Oct 24	-389.74%
Oct 24	-406.36%

Price to Sales

ATXI Price to Sales by year
Period	Price to Sales
Jul 26	0.91
Jul 26	0.65
Jul 26	0.59
Jul 26	0.75
Jul 26	0.72
Jun 26	0.66
Jun 26	0.76
Jun 26	0.75
Jun 26	0.83
May 26	0.7
May 26	0.57
May 26	0.7
May 26	1.24
May 26	1.36
Apr 26	1.47
Apr 26	1.23
Apr 26	1
Apr 26	0.78
Mar 26	0.66
Mar 26	0.66
Mar 26	0.54
Mar 26	0.5
Feb 26	0.43
Feb 26	0.34
Feb 26	0.34
Feb 26	0.43
Jan 26	0.46
Jan 26	0.92
Jan 26	1.59
Jan 26	1.7
Jan 26	1.56
Dec 25	1.46
Dec 25	1.48
Dec 25	1.47
Dec 25	1.74
Nov 25	1.73
Nov 25	1.77
Nov 25	1.72
Nov 25	1.7
Oct 25	1.63
Oct 25	1.61
Oct 25	1.66
Oct 25	1.61
Oct 25	1.59
Sep 25	1.81
Sep 25	1.72
Sep 25	1.86
Sep 25	1.67
Aug 25	1.29
Aug 25	1.32
Aug 25	1.29

EV/EBITDA

ATXI EV/EBITDA by year
Period	EV/EBITDA
May 23	1438.3
Apr 23	1339.38
Apr 23	1452.42
Apr 23	1537.09
Apr 23	1748.79
Mar 23	1642.94

Price to Book

ATXI Price to Book by year
Period	Price to Book
Sep 26	3.47
Sep 26	3.15
Aug 26	2.62
Aug 26	1.49
Aug 26	1.49
Aug 26	1.48
Jul 26	1.07
Jul 26	0.76
Jul 26	0.69
Jul 26	0.88
Jul 26	0.84
Jun 26	0.77
Jun 26	0.9
Jun 26	0.88
Jun 26	0.97
May 26	0.82
May 26	0.66
May 26	0.82
May 26	1.46
May 26	1.04
Apr 26	1.13
Apr 26	0.94
Apr 26	0.77
Apr 26	0.6
Mar 26	0.4
Mar 26	0.4
Mar 26	0.33
Mar 26	0.3
Feb 26	0.26
Feb 26	0.21
Feb 26	0.21
Feb 26	0.26
Jan 26	0.28
Jan 26	0.56
Jan 26	0.97
Jan 26	1.03
Jan 26	0.95
Dec 25	0.89
Dec 25	0.9
Dec 25	0.9
Dec 25	1.06
Nov 25	1.06
Nov 25	1.08
Nov 25	1.05
Nov 25	0.84
Oct 25	0.81
Oct 25	0.8
Oct 25	0.82
Oct 25	0.8
Oct 25	0.79
Sep 25	0.9
Sep 25	0.85
Sep 25	0.92
Sep 25	0.83
Aug 25	0.64
Aug 25	0.65
Aug 25	0.64
Aug 25	0.63
Aug 25	0.59
Jul 25	0.51
Jul 25	0.54
Jul 25	0.47
Jul 25	0.43
Jun 25	0.31
Jun 25	0.38
Jun 25	0.27
Jun 25	0.33
May 25	0.28
May 25	0.27
May 25	0.28
May 25	0.21
May 25	0.22
Apr 25	0.22
Apr 25	0.23
Apr 25	0.22
Apr 25	0.22
Mar 25	0.3
Mar 25	0.35
Mar 25	0.77
Mar 25	0.95
Feb 25	1.07
Feb 25	1.32
Feb 25	1.32
Feb 25	1.18
Jan 25	1.32
Jan 25	1.83
Jan 25	1.79
Jan 25	1.75
Jan 25	2
Dec 24	1.88
Dec 24	1.71
Dec 24	1.74
Dec 24	1.78
Nov 24	2.08
Nov 24	1.95
Nov 24	1.87
Nov 24	0.64
Nov 24	0.65
Oct 24	0.64
Oct 24	0.62

No video analysis for this stock yet. Request one from our team.

News: ATXI

defenseworld.net · 13 Aug 2026

Avenue Therapeutics (NASDAQ:ATXI) and Collegium Pharmaceutical (NASDAQ:COLL) Head-To-Head Survey

Collegium Pharmaceutical (NASDAQ: COLL - Get Free Report) and Avenue Therapeutics (NASDAQ: ATXI - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, analyst recommendations and institutional ownership. Profitability This table compares Collegium Pharmaceutical and

AI Analysis

Avenue Therapeutics, Inc.

Video analysis: ATXI

News: ATXI

Avenue Therapeutics (NASDAQ:ATXI) and Collegium Pharmaceutical (NASDAQ:COLL) Head-To-Head Survey

Similar companies